| Serial Number | 90497620 |
| Word Mark | CVS CLINICAL TRIAL SOLUTIONS |
| Filing Date | Friday, January 29, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 18, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 15, 2022 |
| Goods and Services | Medical personnel and subject recruitment services for clinical trial studies; Conducting pre and post market study surveillance in the field of medical and scientific clinical trials |
| Disclaimer with Predetermined Text | "CLINICAL TRIAL SOLUTIONS" |
| Goods and Services | Medical and scientific research, namely, clinical trial services for others and conducting clinical trials for others; Pharmaceutical and vaccine research and development services; Testing of pharmaceuticals and vaccines; Pharmaceutical and vaccine drug development services; Medical research services relating to pharmaceuticals and vaccines; Providing medical and scientific research information in the fields of pharmaceuticals and vaccines; Medical and scientific research, namely, providing analysis of data obtained from clinical trial studies |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 3, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CVS Pharmacy, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Woonsocket, RI 02895 |
| Party Name | CVS Pharmacy, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woonsocket, RI 02895 |
| Event Date | Event Description |
| Monday, December 18, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 18, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, April 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 20, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, April 20, 2023 | SOU EXTENSION 2 FILED |
| Thursday, April 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 21, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 19, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 19, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, October 19, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 10, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 15, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, February 4, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, February 4, 2022 | ASSIGNED TO LIE |
| Thursday, February 3, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 3, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 3, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 3, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 18, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 18, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 18, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 18, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 2, 2021 | NEW APPLICATION ENTERED |